Abstract:
Objective To investigate the correlation between metabolic syndrome (MetS) and epithelial ovarian cancer (EOC)
Methods A retrospective analysis was performed on the 1, 138 EOC patients hospitalized at Tianjin Medical University Cancer Institute and Hospital between March 2015 and December 2019. Furthermore, 1, 136 health control from participants on physical examination were included to analyze the correlation between EOC incidence risk and clinicopathologic characteristics.
Results Patients in the EOC group showed higher abnormal rate of triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and MetS, hypertension, and diabetes (P < 0.010) than those in the control group. Logistic regression analysis found that MetS age adjusted (OR=4.884; 95%CI:3.704-6.440), TG, and HDL-C levels, hypertension, and diabetes were all associated with the a risk of EOC. MetS was also associated with the International Federation of Gynecology and Obstetrics (FIGO) stageing (OR=1.724, 95%CI:1.215-2.447), tumor differentiation grade (OR=2.725, 95%CI:0.990-3.732), and lymph node metastasis (OR=2.084, 95%CI:1.444-3.006).
Conclusions MetS not only could increases the risk of EOC, and but also MetS helps predicted an advanced FIGO stage, poor differentiation, and lymph node metastasis in EOC patients.